Trial Profile
Efficacy and tolerability of solifenacin in men with overactive bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms MOVE
- Sponsors Astellas Deutschland GmbH
- 01 Dec 2015 New trial record